Skip to Main Content

Paper Details

A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
Cancer Res Treat
1
2024
Author NameAffiliation
Bhumsuk KeamSeoul National University Hospital
Hye Ryun KimYonsei Cancer Center, Yonsei University College of Medicine
Jin-Soo KimSMG-SNU Boramae Medical Center
  • 1 - 3

Datasets

Release 1.2